Karen Daily, DO - Research

Research at a glance

Top areas of exploration

Breast Neoplasms , 10 publications
Neoplasms , 4 publications
Neoplasm Recurrence, Local , 3 publications
Antineoplastic Combined Chemotherapy Protocols , 3 publications

Research activity

41 publications

438 citations

Why is this important?

Active clinical trials

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant

This is a Phase III open-label study to assess if camizestrant improves outcomes compared to standard endocrine therapy in patients with ER+/HER2 * early breast cancer with intermediate or high risk for disease recurrence who completed definitive鈥�

Investigator: Karen Daily
Status: Accepting Candidates
Ages: 18 Years - 130 Years
Sexes: All

My publications

41 publications

2022

Endocrine adherence in male versus female breast cancer: a seer-medicare review.

Breast cancer research and treatment

鈥�

2021

Acinic Cell Carcinoma of the Breast: Report of a Case With Immunohistochemical and Next-Generation Sequencing Studies

International journal of surgical pathology

鈥�

2021

Activity of Sorafenib Plus Capecitabine in Previously Treated Metastatic Colorectal Cancer.

The oncologist

鈥�

2021

ASO Visual Abstract: A 5-Year Breast Surgeon Experience in LYMPHA at Time of ALND for Treatment of Clinical T1-4N1-3M0聽Breast Cancer

Annals of Surgical Oncology

鈥�

2021

Chemotherapy education: current practices of oncology nurses counseling patients.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

鈥�

网红黑料